2nd International Conference on Cardiovascular Medicine and Cardiac Surgery
May 16-17, 2023
|
Chicago, United States of America
Cardiovascular Conference 2023
Venue:Hotel double tree by hilton chicago
About Conference
The "2nd International Conference on Cardiovascular Medicine and Cardiac Surgery" will be held in Chicago, United State of America, on May 16-17, 2023. It will include brief keynote addresses, speaker talks, exhibitions, symposia, workshops, and speaker sessions. Cardiovascular Medicine 2023 encourages all attendees to attend.
Theme: “Latest Research of Cardiac Medicine and Surgical Tool”
The aim of Cardiovascular Medicine 2023 is to provide a revolutionary professional evolution experience that addresses the full spectrum of ongoing research in cardiovascular medicine and innovative technology for cardiac surgery.
To explore methods for treating heart diseases, electrocardiography, heart failure, pediatric cardiology, and other health issues, Cardiovascular Medicine 2023 will bring together top academics, scientists, researchers, physicians, students, percussionists, and cardiologists In order to aid professionals with problems affecting expectations and the search for recently found medications for the treatment of cardiac disease, we have intended to provide a variety of information.
Speakers at this conference are well-known and knowledgeable, covering both general and niche areas of interest. The main goals of our conference are to give cardiovascular doctors, cardiac surgeons, specialists, nurses, technologists, and anyone else professionally involved in cardiovascular disease and molecular cardiology an opportunity to learn about the evolution of the disease, talk about interventional procedures, gain knowledge of new and innovative cardiac surgery, practices, and their efficacy and efficiency in the treatment of various cases, and comprehend local realities.
The 1000+ Global Events handled by LexisConferences Conferences include 300+ Conferences, 500+ Upcoming and Past Symposiums, and Workshops in the USA, Europe, and Asia. LexisConferences Conferences also disseminates 700+ Open Access journals with more than 30000 recognizable figures, reputable experts, and article board members.
Target Audience
Associations and Societies of Cardiology | Business Entrepreneurs | Cardiac-Oncology & Pharmacology | Cardiac Surgeons | Cardiologists | Cardiology and Cardiac Nursing Associations | Cardiology Imaging | Cardiology Students, Scientists | Cardio-thoracic Surgeons | CEOs of Organizations | Clinical EP & Internal Medicine | Directors | Echocardiography | Emergency Medicine | Endocrinology | General Cardiology | Healthcare Industries | Cardiology Manufacturing Companies | Medicine Experts | Paediatric & Preventive Cardiology | Paediatric Cardiologists | Paediatric Care Centres | Professors, Associate Professors | Research Institutes | Research Scholars | Researcher | Vascular Biologists
Participation Options and Benefits
We provide the participants with different modes or ways to participate as Delegate or Speaker under the ACADEMIC / STUDENT / BUSINESS Category. The mode of participation is webinar through PowerPoint Presentation/ Video Presentation.
- Keynote speaker: 45-50 minutes
- Speaker (oral presentation): 25-30 minutes (only one person can present)
- Speaker (workshop): 45-50 minutes (more than 1 can present)
- Speaker (special session): 45-50 minutes (more than 1 can present)
- Speaker (symposium): more than 45 minutes (more than 1 can present)
- Delegate(only registration): will have access to all the sessions with all the benefits of registration
- Poster presenter: can present a poster and enjoy the benefits of delegateRemote attendance: can participate via video presentation or e-poster presentation
- Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
PARTICIPATION BENEFITS
- Attend Keynote presentations by world’s most eminent researchers
- Access to all the sessions
- Get OCM certificate
- Get worldwide acknowledgment to your profile and Research
- Get your abstracts published with unique DOI in International Journals
- Get up to 50% discounts for publishing your entire article in our open-access International Journals
- Get Handbooks and conference kits
- Get access to the network with eminent personalities from worldwide
Supporting Journals
All the selected Abstracts/ papers presented will be published in the Supporting Journals below:
• Journal Name: Journal of Clinical & Experimental Cardiology
• Journal Name: International Journal of Medical Research & Health Sciences
• Journal Name: International Journal of Cardiovascular Research
Join our team Cardiovascular Medicine 2023 in this beautiful city of Chicago and let us make this professional gathering a Great success.
Market Analysis
At a compound annual growth rate (CAGR) of 4.8%, the market for cardiovascular medications worldwide is anticipated to increase from $146.51 billion in 2021 to $153.60 billion in 2022. The companies' reorganization of operations and recovery from the COVID-19 impact, which had previously resulted in restrictive containment measures involving social estrangement, remote work, and the closure of commercial activities that created operational challenges, are primarily responsible for the growth. At a CAGR of 4%, the market is anticipated to reach $107.77 billion in 2025. The market for cerebral embolic protection devices is expected to develop at the quickest rate in the global cardiac surgery market, with a predicted value of approximately $14.2 billion in 2021. Despite COVID-19, it is anticipated that the size of the global market would rise throughout the projection period and surpass $20.4 billion by 2027.
Etiology, clinical characteristics, and therapy
Cardiomyopathies were the cause of heart failure in 28% of patients, followed by rheumatic heart disease in 12%, ischemic heart disease in 9%, and hypertension in 45% of patients. Other causes (like probable tuberculosis- or HIV-related cardiomyopathies, end myocardial fibrosis, and obstructive lung disease) accounted for 6% of the cases. Heart Failure caused by idiopathic dilated cardiomyopathy was the most common cardiomyopathy among those who had it (81%) and was followed by postpartum cardiomyopathy (15%). Hypertrophic and restrictive cardiomyopathies were uncommon (5 %). The most common valvular lesion was a rheumatic mitral disease with regurgitation (81%) followed by mitral stenosis (15%) and aortic regurgitation (3 %).
Importance and Scope
The greatest venue for scientists, cardiologists, oncologists, electro physiologists, surgeons, nurses, research scholars, and students working in this field to exchange knowledge about cardiology and cardiac surgery will be Cardiovascular Medicine 2023. An alternative to invasive imaging techniques against heart illnesses and heart failure problems in adults and children is being sought through this worldwide event.
Growth of the Cardiology Market
In 2022, the market size for cardiologists is predicted to grow by 2.6 percent. Between 2017 and 2022, the US Cardiologists market size increased by an average of 1.1 percent annually.
Statistics of Physicians, Researchers, and Academicians working on Cardiology Research
Directors, Heads, Deans, Professors, Scientists, Researchers, Doctors, Students, and Writers of the Pediatric Cardiology Department, as well as the Founders and Employees of Related Companies, Associations Members, Related Organizations, Laboratories Members, etc., make up the major portion of the world associated with the Cardiology field.
Inhibiting the progression of congestive heart failure through pharmacological, device-based therapies is a key objective of heart failure therapy. As a result, attempts have been made to create device-based therapies with the goal of enhancing cardiac reserve and increasing pump performance to satisfy metabolic requirements. Congestive heart failure frequently progresses more slowly due to additional factors that affect outcomes, such as new-onset arrhythmias, ischemia and infarction, valvulopathy, decompensation, end-organ damage, and therapeutic refractoriness. Sometimes, minor pathophysiologic changes presage the start of such illnesses, and prompt detection of these changes may encourage the adoption of preventative interventions. As a result, device-based approaches may play a crucial part in the prompt detection of the subtle pathophysiologic alterations linked to congestive heart failure in the future.
Related Companies/Industries
MEDNAX, Inc. | AstraZeneca | Sanofi | Boehringer Ingelheim | Roche |Bristol-Myers Squibb | United Therapeutics | Astellas | Actelion | Takeda | Otsuka | Gilead Sciences
Related Associations and Societies
American Association of Heart Failure Nurses (AAHFN) | American Society of Nuclear Cardiology (ASNC) | American Society for Echocardiography | Pediatric Cardiology Associates.
Related Universities
University Maastricht | Academic Hospital Maastricht | Medical University of Graz | University of Debrecen Medical School | University of Nicosia Medical School | Imperial College London| Johns Hopkins University | Bukovina State Medical University | Heidelberg University | Hamburg University | University of Lodz | Yale University | North-western University | Vanderbilt University | University of Rochester
Contact info:-
Austin Welch
Program manager| Cardiovascular Medicine 2023
Email: [email protected]
Contact us: +44 (203) 966-4288,
What’s App: +44- 7897073589
Call for Submissions
Abstracts will be reviewed by the Abstract Review Board (ARB) of the conference
- Acute Coronary Syndrome
- Cardio Metabolic
- Cerebrovascular Disease And Stroke
- Congenital Heart Disease
- Coronary, Peripheral Structural Interventions
- Cardio-Oncology
- Cerebrovascular Disease Stroke
- Critical Care Resuscitation
- Cardiac Imaging
- Cardiac Disease Pathology
- Cardiac Surgery Tool
- Cardiac Arrest
- Cardiac Medicine And Nanomedicine
- Cardiac Pathophysiology
- Cardiovascular Care
- Cardiac Rehabilitation
- Genetics, Omics Tissue Regeneration
- Health Promotion And Preventive Cardiology
- Heart Failure And Cardiomyopathies
- Hypertension
- Ischemic Heart Disease
- Myocardial Infraction
- Pediatric Cardiology
- Pacemaker Therapy
- Rhythm Disorders Electrophysiology
- Echocardiography
- Cardiovascular disease
- Posttraumatic Stress Disorder
- Cardiac Psychology
- Nuclear Cardiology
- Heart Disease and Relaxin
- Cardiac anaesthesia
Biography
Prof. Joseph Shemesh, MD, Director of the Shibat Medical Screening Center. Prof. Shemesh has completed his medical education at the University of Paris VII Premier cycle des etudes Medicales and the Sackler School of Medicine, TAU. He serves as Clinical professor of Cardiology, at the Sackler School of Medicine, TAU. He is a recipient of the Prof Richard, Hilda and Ezra Meltzer Memorial Award for the contribution to the development of non invasive detection of subclinical coronary atherosclerosis. Member in Israel Heart Society and European Heart Society. Prof. Shemesh acts as a Chairman of the Working Group on Epidemiology and Prevention; active participant in scientific meetings. Prof. Shemesh is a largely published author with over 70 publications in the scientific literature.
Researches :
- The role of the MESA-Calcium Score in statin treatment allocation in asymptomatic adults
Biography
Dr. Jay Porter III, DO is a Family Medicine Specialist in Hermitage, PA and has over 23 years of experience in the medical field. He graduated from Lake Erie College Of Osteopathic Medicin--Erie in 2000. He is affiliated with medical facilities such as Cleveland Clinic Martin North Hospital and Sharon Regional Medical Center - Emergency Care Center. His office accepts new patients.
Biography
Dr. Lu Liu, with a doctor's degree, majored in cardiovascular disease, is committed to the research of heart failure and artificial intelligence. She is deeply interested in proposing a prediction model for cardiovascular disease. This model is used to predict patients with left ventricular inversion and reconstruction and is expected to expand the amount of data in the future and realize the transformation of achievements.
Researches :
- Early prediction of clinical scores for left ventricular reverse remodeling using extreme gradient random forest, boosting, and logistic regression algorithm representations
Biography
Al Namat Razan – Assistant Professor, MD, PhD (PhD Thesis : Researches on the effects of antioxidant medication and cardiovascular recovery in patients with aortic-coronary bypass, transluminal percutaneous angioplasty or acute myocardial infarction; Assistant Professor, “Grigore T. Popa” University of Medicine and Pharmacy, Faculty of Medicine, 1st Medical Department, subject – Internal Medicine, Cardiology Clinic, “Sf. Spiridon" Emergency Clinical County Hospital of Iasi; Specialist in Cardiology, "Sf. Spiridon" Emergency Clinical County Hospital of Iasi, active member – European Society of Cardiology (ESC), active member- European Association of Percutaneous Intervention (EAPCI), active member- EACVI, active member- HFA, active member EAPC, active member- ACVC, active member – Romanian Society of Cardiology (SRC). Al Namat Razan – Assistant Professor, MD, PhD (PhD Thesis : Researches on the effects of antioxidant medication and cardiovascular recovery in patients with aortic-coronary bypass, transluminal percutaneous angioplasty or acute myocardial infarction; Assistant Professor, “Grigore T. Popa” University of Medicine and Pharmacy, Faculty of Medicine, 1st Medical Department, subject – Internal Medicine, Cardiology Clinic, “Sf. Spiridon" Emergency Clinical County Hospital of Iasi; Specialist in Cardiology, "Sf. Spiridon" Emergency Clinical County Hospital of Iasi, active member – European Society of Cardiology (ESC), active member- European Association of Percutaneous Intervention (EAPCI), active member- EACVI, active member- HFA, active member EAPC, active member- ACVC, active member – Romanian Society of Cardiology (SRC).
Researches :
- Surgical revascularization therapy – risk factors, techniques, and periprocedural and remote complications during 10-years follow-up
Researches :
- ONE HEART, ONE MIND, ONE PLANET: Behavioral Cardiology - The Elephant in Your Living Room
Researches :
- Current applications of robotic surgery in management of cardiac diseases
Researches :
- Evolution & current status of MICS
Researches :
- Intraventricular Thrombolysis for LVAD Thrombosis
Researches :
- Case of tachycardia induced cardiomyopathy during pregnancy: clinical presentation and management
Researches :
- Updates in the management of dyslipidemia for primary & secondary prevention
Researches :
- Can pre-operative patient factors predict permanent pacemaker implantation after Coronary Artery Bypass Grafts (CABG)?
Researches :
- Prescription Trends and Healthcare Expenditure of beta-blockers in heart failure with reduced ejection fraction in Australia in the last five years
Researches :
- Efforts to establish a collaborative heart transplant program : An experience of international society for heart & lung transplant
Researches :
- Powering Biopharma research with Data and Genomics – the time is now
Researches :
- Assessment of cardiorespiratory fitness of individuals after stroke
Researches :
- The impact of anemia on long-term mortality among post-acute myocardial infarction patients according to different levels of chronic kidney disease
Researches :
- Association of 2D Echocardiogram Findings and Survival Rate in Severe and Critical COVID-19 Adult Patients: A Single Center Retrospective Study
Researches :
- Preferential Binding Of Oxidized Fat By Polyglucosamine L112
Researches :
- Nature and Intensity of Angina Symptoms: Association between Seattle Angina Questionnaire, Canadian Cardiovascular Class and Rose Angina Questionnaire in the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial
Biography
Prof. Dr. Seyed Saeid Zamanieh Shahri, is a faculty member at California Northstate University, CNSU, and a university Professor in Losrios Community College District, USA. He is an editorial board member in International Medical Journals in the Unit...
Researches :
- Interventional Radiology and Cardiology
Biography
Dipak Ramji is a Professor of Cardiovascular Science and Deputy Head at the School of Biosciences at Cardiff University. He is also a Fellow of the Learned Society of Wales. He received his BSc (Hons) degree (Biochemistry) and his Ph.D
Researches :
- Atherosclerosis and Cardiovascular Disease
Program Overview
Our Collaborations, Sponsors, Media Partners
